Skip to main content
editorial
. 2018 Dec 27;3(1):e169. doi: 10.1097/HS9.0000000000000169

Figure 1.

Figure 1

A heatmap representation of the prevalence of gene alterations in mature B lymphoid malignancies from the LYSA/GBMHM consensus panel. The ∗ symbol for CDKN2A underlines that this locus is altered by deletions (and not mutations). The borders of the squares are colored when the alteration has a clear clinical impact in a particular lymphoma subtype (diagnostic in yellow, prognostic in red, and theranostic in blue). ABC = activated B cell, BL = Burkitt lymphoma, CLL = chronic lymphocytic leukemia, DLBLCL = diffuse large B cell lymphoma, FL = follicular lymphoma, GC = germinal center, HCL = hairy cell lymphoma, HL = Hodgkin lymphoma, MCL = mantle cell lymphoma, MZL = marginal zone lymphoma, PCNSL = primary central nervous system lymphoma, PMBCL = primary mediastinal B cell lymphoma, WM = Waldenström macroglobulinemia.